109 related articles for article (PubMed ID: 2494449)
1. Bioreduction of 4-nitroquinoline 1-oxide in dysplastic nevus syndrome fibroblasts.
Mirzayans R; Sabour M; Paterson MC
Mutat Res; 1989 Apr; 225(4):165-9. PubMed ID: 2494449
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bioreduction of 4-nitroquinoline 1-oxide by cultured ataxia telangiectasia cells.
Mirzayans R; Sabour M; Paterson MC
Carcinogenesis; 1988 Sep; 9(9):1711-5. PubMed ID: 3136948
[TBL] [Abstract][Full Text] [Related]
3. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
Sato K; Howell JN; Greene MH; Maher VM; McCormick JJ
Cancer Res; 1988 Sep; 48(18):5145-50. PubMed ID: 3136916
[TBL] [Abstract][Full Text] [Related]
4. Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma.
Smith PJ; Greene MH; Adams D; Paterson MC
Carcinogenesis; 1983; 4(7):911-6. PubMed ID: 6409440
[TBL] [Abstract][Full Text] [Related]
5. Hyperresistance to 4-nitroquinoline 1-oxide cytotoxicity and reduced DNA damage formation in dermal fibroblast strains derived from five members of a cancer-prone family.
Mirzayans R; Sabour M; Rauth AM; Paterson MC
Br J Cancer; 1993 Nov; 68(5):838-44. PubMed ID: 8217598
[TBL] [Abstract][Full Text] [Related]
6. Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide.
Howell JN; Greene MH; Corner RC; Maher VM; McCormick JJ
Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1179-83. PubMed ID: 6422469
[TBL] [Abstract][Full Text] [Related]
7. Caffeine inhibition of the metabolic activation of a carcinogen, 4-nitroquinoline-1-oxide, in cultured Chinese hamster cells.
Tsuda H; Yoshida D; Mizusaki S
Carcinogenesis; 1984 Mar; 5(3):331-4. PubMed ID: 6200248
[TBL] [Abstract][Full Text] [Related]
8. Polyclonal antibodies to DNA modified with 4-nitroquinoline 1-oxide: application for the detection of 4-nitroquinoline 1-oxide-DNA adducts in vivo.
Morita T; Ikeda S; Minoura Y; Kojima M; Tada M
Jpn J Cancer Res; 1988 Feb; 79(2):195-203. PubMed ID: 3130354
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity to cell killing and faulty repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in human (ataxia-telangiectasia) fibroblasts treated with 4-nitroquinoline 1-oxide.
Mirzayans R; Smith BP; Paterson MC
Cancer Res; 1989 Oct; 49(20):5523-9. PubMed ID: 2507129
[TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of tyrosinase increases melanin synthesis and cell death following UVB irradiation in fibroblasts from familial atypical multiple mole and melanoma (FAMMM) patients.
Yoneta A; Yamashita T; Jin HY; Kondo S; Jimbow K
Melanoma Res; 2004 Oct; 14(5):387-94. PubMed ID: 15457095
[TBL] [Abstract][Full Text] [Related]
11. Clustered repair of excisable 4-nitroquinoline-1-oxide adducts in a larger fraction of genomic DNA of xeroderma pigmentosum complementation group C cells.
Fujiwara Y
Carcinogenesis; 1989 Oct; 10(10):1777-85. PubMed ID: 2507185
[TBL] [Abstract][Full Text] [Related]
12. The repair of identified large DNA adducts induced by 4-nitroquinoline-1-oxide in normal or xeroderma pigmentosum group A human fibroblasts, and the role of DNA polymerases alpha or delta.
Jones CJ; Edwards SM; Waters R
Carcinogenesis; 1989 Jul; 10(7):1197-201. PubMed ID: 2500268
[TBL] [Abstract][Full Text] [Related]
13. Reduction of 4-nitroquinoline 1-oxide to 4-hydroxyaminoquinoline 1-oxide in lysates of cytomegalovirus-infected cells.
Speelman DJ; Lund H; Culling A; Kittredge JS; Williams BJ; Albrecht T
J Gen Virol; 1983 Nov; 64 (Pt 11)():2511-5. PubMed ID: 6315869
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 4-nitroquinoline 1-oxide and related compounds.
Tada M
Carcinog Compr Surv; 1981; 6():25-45. PubMed ID: 6786744
[No Abstract] [Full Text] [Related]
15. [An experimental study of the penetration of 4-nitroquinoline-1-oxide (4NQO) in the oral mucosa and ultrastructure of the papillae of the rat dorsal tongue].
Mochizuki A
Shikwa Gakuho; 1985 Aug; 85(8):1169-98. PubMed ID: 3937244
[No Abstract] [Full Text] [Related]
16. Mechanism of increased susceptibility to 4-nitroquinoline-1-oxide in cultured skin fibroblasts from patients with familial polyposis coli.
Akamatsu N; Miyaki M; Suzuki K; Ono T; Sasaki MS
Mutat Res; 1983 May; 120(2-3):173-80. PubMed ID: 6405266
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of enzymic incision of thymine dimers by covalently bound guanine adducts of 4-nitroquinoline-1-oxide in DNA.
Duker NJ; Merkel GW
Cancer Res; 1986 May; 46(5):2374-6. PubMed ID: 3084066
[TBL] [Abstract][Full Text] [Related]
18. DNA damage and its repair in human normal or xeroderma pigmentosum fibroblasts treated with 4-nitroquinoline 1-oxide or its 3-methyl derivative.
Mirzayans R; Waters R
Carcinogenesis; 1981; 2(12):1359-62. PubMed ID: 6799219
[TBL] [Abstract][Full Text] [Related]
19. Inverse correlation between p53 protein levels and DNA repair efficiency in human fibroblast strains treated with 4-nitroquinoline 1-oxide: evidence that lesions other than DNA strand breaks trigger the p53 response.
Mirzayans R; Bashir S; Murray D; Paterson MC
Carcinogenesis; 1999 Jun; 20(6):941-6. PubMed ID: 10357771
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between hypersensitivity to cell killing and impaired inhibition of DNA synthesis in ataxia telangiectasia fibroblasts treated with 4-nitroquinoline 1-oxide.
Mirzayans R; Paterson MC
Carcinogenesis; 1991 Jan; 12(1):19-24. PubMed ID: 1899054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
